Abstract

Introduction Croatia is among the EU Member States with the highest expenditure on medical goods, mainly pharmaceuticals, amounting to 28.5%, compared to an EU average of 18.5%. In addition, a continuous increase in the prevalence of chronic medical conditions with the accompanying polypharmacy has been noted. Hence, chronic patients are at an increased risk of experiencing drug therapy problems (DTPs), thus adding substantial costs to the health care system and exceeding the amount spent on the medications themselves.Short description of practice change implemented To ensure patients’ optimal medication use and improve their clinical outcomes, a comprehensive and systematic management of medications is deemed crucial. Comprehensive Medication Management (CMM) services, officially recognized by the Federal Government of the USA in 2003 (MMA 2003), address this problem. Collaborative practice between pharmacists and general practitioners (GPs), together with patients’ active participation in the definition of treatment regimens, plays an important role in the effectiveness of CMM services.AimThe primary aim of this study is to describe the newly implemented practice management system of CMM services at the county health centre in Croatia.Targeted population and stakeholders• patients who have not reached or are not maintaining the intended therapy goal• patients who are experiencing adverse effects from their medications• patients who have difficulty understanding and following their medication regimen• patients in need of preventive therapy• patients who are frequently readmitted to the hospital Timeline2016 - 2018 Components of the practice management system adapted to Croatian primary health care setting2017- The work flow of the patient care process specific for Croatian primary care level defined2018- Pharmacotherapy counselling service, located in the county health centre, Health Centre Zagreb- Centre, established and started with its workHighlights (innovation, Impact and outcomes)At least one DTP was identified in 81 (96.2%) patients, of which 30.2% had 4 or more DTPs. The most prevalent DTP was “Needs additional therapy” (26.1%), with “Untreated condition” being the most common cause. The second most frequent DTP category was “Dosage too low” (24.5%), followed by “Unnecessary drug therapy” (12.4%) and “Dosage too high” (11.6%).Comments on sustainabilityAs this is a pilot-project, sustainability of the service has not yet been ensured.Comments on transferabilityComponents of the practice management system and protocol on the workflow of the patient care process specific for Croatian primary care level are available to all primary care units in Croatia.Conclusions (comprising key findings)A new pharmacist-led service was successfully piloted and introduced at the Croatian primary health care clinic.DiscussionsA deeper understanding of work processes and resources needed for initial implementation of CMM were of paramount importance for successful introduction of CMM within a primary care setting.Lessons learnedChallenges encountered throughout the process of initial implementation of CMM services were detected; they should be tackled for full implementation of CMM services and need to be taken into consideration in future implementation of this service in other health care settings.

Highlights

  • Croatia is among the EU Member States with the highest expenditure on medical goods, mainly pharmaceuticals, amounting to 28.5%, compared to an EU average of 18.5%

  • Chronic patients are at an increased risk of experiencing drug therapy problems (DTPs), adding substantial costs to the health care system and exceeding the amount spent on the medications themselves

  • The primary aim of this study is to describe the newly implemented practice management system of Comprehensive Medication Management (CMM) services at the county health centre in Croatia

Read more

Summary

Introduction

Croatia is among the EU Member States with the highest expenditure on medical goods, mainly pharmaceuticals, amounting to 28.5%, compared to an EU average of 18.5%. A continuous increase in the prevalence of chronic medical conditions with the accompanying polypharmacy has been noted. Chronic patients are at an increased risk of experiencing drug therapy problems (DTPs), adding substantial costs to the health care system and exceeding the amount spent on the medications themselves

Short description of practice change implemented
Targeted population and stakeholders
Comments on transferability
Findings
Lessons learned
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.